OpenAlex
PricingAboutJobs
Log inGet started
Work

Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk

HTML

Year: 1999
Type: article
Study design: Observational Study
Source: Haemophilia
DOI: 10.1046/j.1365-2516.1999.t01-1-00303.x
Authors: E. C. THORLAND, J. B. DROST, J. M. LUSHER, I. WARRIER, A. SHAPIRO, M. A. KOERPER, D. DIMICHELE, J. WESTMAN, N. S. KEY, S. S. SOMMER
Institutions: Mayo Clinic, City Of Hope National Medical Center, City of Hope, Children's Hospital of Michigan, Riley Hospital for Children, University of California San Francisco Medical Center, Nationwide Children's Hospital, University of Minnesota Medical Center
Language: English

Topic: Hemophilia Treatment and Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: hemophilia B, factor IX replacement therapy, anaphylaxis, missense mutations, partial gene deletion, genotype-phenotype correlation, coagulation factor IX
SDG: Good health and well-being

Open Access status: closed

Funder: National Heart, Lung, and Blood Institute
Award: DELINEATION OF CAUSATIVE MUTATIONS IN HEMOPHILIA
OpenAlex ID: W2054948386
FWCI: 1.986
Cites: 29
Cited by: 107
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security